Drug use evaluation: RESULTS(1)

Drug use evaluation: RESULTS(1)

A total of 704 data collection forms were received. Of these, 246 had to be rejected. Reasons for rejection included no information on diagnosis (59.8%), information on diagnosis unclear (29.3%), no recommendation available in both references for the indication being treated (8.9%), and other data missing such as name of the drug, dose, etc (2%). (Table 1). A total of 458 data collection forms qualified for data analysis. From these, 477 prescriptions were analyzed. Quite a wide range of conditions were treated (ie, dermatological, sexually transmitted, urogenital, enteric and respiratory infections) (Table 2). buy ampicillin

TABLE 1 Rejected data collection forms

Category n (%)* Comments
No information on diagnosis 147 (59.8) Breakdown based on prescriber type: PA: 27.9%GP: 66.2%SP: 5.9%
Diagnosis unclear 72 (29.3) Diagnosis information on data collection form does not allow to match accurately with an indication
No recommendation available 22 (8.9) No recommendation available in the guidelines for the indication for which the Rx was written
Other data missing or unclear Total 5 246 (34.9) Example: unable to identify antibiotic prescribed A total of 704 data collection forms were received, of which 246 (34.9%) were rejected

GP General practitioner; PA Physician assistant; Rx Prescription; SP Specialist. Indicates percentage each category represents based on the 246 data collection forms that were rejected

TABLE 2 Indications

Indications n (%)
Acne 1 (0.2)
Atypical pneumonia 11 (2.3)
Balanitis 1 (0.2)
Bite injury 2 (0.4)
Blepharitis 1 (0.2)
Bronchitis 84 (17.6)
CAP 32 (6.7)
Cellulitis 30 (6.3)
Cervicitis 2 (0.4)
Cystitis 1 (0.2)
Dental abcess 1 (0.2)
Diverticulitis 1 (0.2)
Epididymitis 9 (1.9)
Folliculitis 9 (1.9)
Helicobacter pylori 3 (0.6)
Impetigo 2 (0.4)
Laryngitis 1 (0.2)
Otitis externa (acute) 4 (0.8)
Otitis externa (chronic) 1 (0.2)
Otitis media (acute) 61 (12.8)
Otitis media (chronic) 1 (0.2)
Paronychia 3 (0.6)
Pharyngitis or tonsillitis 97 (20.3)
PID (chlamydia) 2 (0.4)
Prostatis 3 (0.6)
Salpingitis 1 (0.2)
Sinusitis (acute) 75 (15.7)
Sinusitis (chronic) 5 (1.0)
Traveler’s diarrhea 1 (0.2)
Urethritis 2 (0.4)
UTI (uncomplicated) 28 (5.9)
Vaginosis 2 (0.4)

CAP Community-acquired pneumonia; PID Pelvic inflammatory disease; UTI Urinary tract infection

A breakdown of the main conditions (ie, representing at least 5% of the total number of prescriptions) treated by each prescriber type is presented in Table 3. We have observed that 73% of the prescriptions analyzed during this DUE were for the treatment of infections related to the respiratory system: bronchitis, community-acquired pneumonia (CAP), otitis media (OM), pharyngitis and sinusitis.

TABLE 3 Main conditions treat by prescriber

Indication Total number of Rxs (%) Number of PA Rxs (%) Number of GP Rxs (%)
Pharyngitis 97 (20.3) 66 31
Bronchitis 84 (17.6) 44 40
Sinusitis 75 (15.7) 34 41
OM 61 (12.8) 41 20
CAP 32 (6.7) 14 18
Cellulitis 30 (6.3) 16 14
UTI 28 (5.9) 12 16

CAP Community-acquired pneumonia; GP General practitioner; OM Otitis media; PA Physician assistant; Rx Prescription; UTI Urinary tract infection

This entry was posted in Drug use and tagged Ambulatory care setting, Anti-infectives, Drug use eval.